Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer
Author(s) -
Qinglei Gao,
Zongyuan Yang,
Sen Xu,
Xiaoting Li,
Xin Yang,
Ping Jin,
Yi Liu,
Xiaoshui Zhou,
Taoran Zhang,
Gong Cheng,
Wei Xiao,
Dan Liu,
Chaoyang Sun,
Gang Chen,
Junbo Hu,
Meng Li,
Jianfeng Zhou,
Kenjiro Sawada,
Robert Fruscio,
Thomas W. Grunt,
Jörg Wischhusen,
Víctor Manuel Vargas-Hernández,
Bhavana Pothuri,
Robert L. Coleman
Publication year - 2019
Publication title -
the journal of experimental medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.483
H-Index - 448
eISSN - 1540-9538
pISSN - 0022-1007
DOI - 10.1084/jem.20180765
Subject(s) - ovarian cancer , stromal cell , serous fluid , stroma , metastasis , cancer research , cancer associated fibroblasts , medicine , cancer , pathology , cancer cell , tumor microenvironment , biology , immunohistochemistry , tumor cells
High-grade serous ovarian cancer (HGSOC) is hallmarked by early onset of peritoneal dissemination, which distinguishes it from low-grade serous ovarian cancer (LGSOC). Here, we describe the aggressive nature of HGSOC ascitic tumor cells (ATCs) characterized by integrin α5 high (ITGA5 high ) ATCs, which are prone to forming heterotypic spheroids with fibroblasts. We term these aggregates as metastatic units (MUs) in HGSOC for their advantageous metastatic capacity and active involvement in early peritoneal dissemination. Intriguingly, fibroblasts inside MUs support ATC survival and guide their peritoneal invasion before becoming essential components of the tumor stroma in newly formed metastases. Cancer-associated fibroblasts (CAFs) recruit ITGA5 high ATCs to form MUs, which further sustain ATC ITGA5 expression by EGF secretion. Notably, LGSOC is largely devoid of CAFs and the resultant MUs, which might explain its metastatic delay. These findings identify a specialized MU architecture that amplifies the tumor-stroma interaction and promotes transcoelomic metastasis in HGSOC, providing the basis for stromal fibroblast-oriented interventions in hampering OC peritoneal propagation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom